.AMONG the many complications suffered by patients with Waldenstriim's macroglobulinemia are those related to increased blood viscosity.16 These include vascular stasis, retinopathy, and a bleeding disorder due to acquired functional thrombopathy. 4 T h e latter is considered due to coating of platelets by macroglobulin, rendering them incapable of participating normally in the coagulation process.11 Plasmapheresis, a procedure well within the capability of the medium-sized laboratory, can reduce viscosi ty rapidly by lowering serum macroglobulin levels and, as a result, alleviate related symptoms. T h e three patients reported below exemplify the usefulness of this form of treatment.
Materials and Methods

P r o t e i n studies
Imrnunoelectrophoresis of serum was pcrformed on agar gel-coated glass microscope slides using horse or goat polyvalent antihuman serum. Photographic prints were made using the glass slide with the precipitin bands as a negative. By noting density and width of the immunoglobulin arcs, rough semiquantitative e.stimates of these proteins were made.
Total proteins were determined by the biuret reactions, as adapted to the AutoAnalyzer. Routine serum electrophoresis was performed o n cellulose acetate strips, buffered with barbital
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at pH 8.6 to 1.5 niilliamperes pcr strip for 60 minutes.
Quantitative radial immunodiffusiori o f serum was performed using coniniercially olltained agar rontaining anti-IgG, anti-Ig:\, and antiIghI.* I n the presence of the corresponding antigen the diainetcr of the resulting circular prccipitin band is a logarithmic function of antigen concentration.9 O u r laboratory's normal values (nig per 100 ml) arc: IgG, 550-1,500; IRA, 70-400; and IghI, 40-200.
Plnstnapheresis
Plasmapheresis as employed at the University of Michigan Medical Center previously has been described.13 A unit of blood is removed from the patient, centrifuged, and the packed cells and plasma are separated. 'I'he packed cells are returned to the patient ;ind the plasma is discarded. This is repeated until approxiniately 500 to GOO ml of plasnia are removed; the process requires 60 to 90 minutes. I n anemic patients more plasma m;iy be removed from each unit of whole blood due to the patient's reduced packed cell volume.
Case Reports
Case 1: A 39-year-old white male attorney (UMMC #072187), on whom a diagnosis of hemolytic anemia had been made three months previously, failed to improve on adrentrcorticosteroid therapy.
On admission lie complained of weakness, fatigue, and exertional djspriea of approximately four months' duration. He had Cushingoid facies and retinopathy with exudates, splinter hemorrhages and dilated sausage-shaped veins. Sternal tenderness, hepatosplenorncgaly, and lower. extremity ecchymoses were present.
Pertinent laboratory values wrre: hemoglobin. Treatment with hydrocortisone, 200 mg daily. was begun the day after admission, but three weeks later the hematocrit was virtually unchanged. hlultiple transfusions of packed cells were given. Splenectomy was perfornictl n i t the twenty-sixth hospital day, and hydt ocortisone was rcduced to 80 mg daily. T h e patient was discharged on the forty-ninth day with a hematocrit of 337,.
He was treated as an outpatient with chloratiibiicil and hydrocortisone for the following 16 months during which pvriod his hematocrit was about 40% and his reticuloc) tes were normal.
He complainctl of easy fatigue at his second hospital adiiiission. Except for slight prctibial edema, physical examination was unremarkable. Neither retinopathy nor hcpatorttcgaly was present.
Pertinent laboratory values included Hct, 23%; WBC, 5,750 per CII mtn; platelets, 10,000 per cu mm: and hemoglobin, 7.8 g per 100 ml. Poikilocvtosis, anisocytosis, antl roulc.aux again were present in the peripheral blood sfnear. His total serum protein was 9.2 g per 100 ml with 4 O ? i y globuliir, largely monoclonal. IgM concentration was greater than 500 mg per 100 ml. IgG was 1,100 mg per 100 ml, and IgA was 115 mg per 100 ml.
Treatment with cyclophosphamide, 150 mg per day, instituted two weeks before his final admission, was continued, as was hydrocortisone. He had repeated episodes of epistaxis, requiring approximately two transfusions per week to maintain his hematocrit in thc range of 35Y0. Phenylalanine mustard in an average dose of 3 mg per day, was substittited for qclophosphamide on the twentyninth hospital day. Gross hematuria occurred on the fifty-fifth day.
During the following 15 days, I8 units of plasma (approxiniately 6,000 nil) were removed, resulting in a decrease in total serum proteins and y globulins (Table I ) , as well as lowering of the serum viscosity, relative to water, from 11.5 units to 3.5 units (Fig. I ) . T h e seruni albumin level remained constant.
Anemia and thrombocytopenia persisted. llepcal bone marrow examination revealed nearly cotnplete replacement by lymphocytes and plasma cells. He was discharged on the seventy-fourth hospital day. He died suddenly at home ten days later. Autopsy was not performed. Additional studies demonstrated spontaneous gelling of her plasma, positive Sia water and C T~O -globulin tests, and cold agglutinins in the serum.
T h e serum uric acid was 7 mg per 100 ml. T h e RISA 1 3 1 1 plasma volume was estimated at 5,700 nil. Her serum viscosity was 8.5 units. ' l h e abnormal globulin was identified as IgM by immunoelectrophoresis.
Immunodiffusion revealed IgM coticctttration at 6.50 nig per 100 ml; I@;, 1,500 mg per 100 nil; and IgA, 200 mg per 100 nil. Berause of the patient's retinopathy plasmaplieresis was instituted. After removal of four units of plasma, her total serum protein had fallen to 8.5 gyu (albumin, 38 
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* 0 * * * * * on her white blood coiitit. Slic noted further i nproved vision in her left eye oiie niouth later, her spleen no longer was palpal)le, the hemoglobin hat1 risen to 9.6 g per I O ( i n i l . and there was m;irkecl decrease in rouleaux formation seen on the peripheral blood film. T h e total protein was still 8.4 g per 100 in1 with 50.6<,';, albumin and 27.70,, y globulin. Three months later, her serum viscosity was three units and IgM was 400 mg/100 ml. On her most recent clinic visit over a year later, the patient was asymptomatic, the liver and spleen could not be felt, antl her eye grounds revealed slightly tortuous veins, pinpoint white exudates, hut no new hemorrhages.
Case 3: (UMMC #1057362).
A 55-year-old white woman complained of blurred vision, easy bruisability, and epistaxis. Two months before admission, she had been hospitalized elsewhere for upper gastro-intestinal bleeding and received four units of whole blood, and one month before adinission she presented at another hospital with ophthalmopathy. monoclonal gamniopathy, and markedly elevated IgM levels.
Her blood pressure at the time of admission was 140/90 mm Hg, her neck veins were distended, and a few cutaneous petechiae were present. Bilateral retinal hemorrhages, venous segmentation, and tortuosity were seen on fundoscopy. There was no lymphadenopathy, but hepatosplenomegaly was present.
Pertinent initial laboratory data included hemoglobin, 8.5 g per 100 ml; Hct, 27Y0; white blood cell count, 10,600 per cu ml (55y0 lymphocytes); normal platelet count; prominent rouleaux; and positive cryoglobulin and Sia water tests. Her total serum protein concentration was 11.4 gm per 100 ml (albumin, 33.67,: al globulin, 2.0Y0; a2 globulin, 5.6%; p globulin, 7.5OL; and y globulin, 51.40/,). T h e elevated y globulin was manifest as a tall narrow-basrd monoclonal spike on electrophoretogram, antl was identified as IgM by immunoelectrophoresis. IghI was greater than 7,000 mg per 100 ml, IgC was 300 mg per 100 ml, and IgA was less than 66 mg per 100 ml. Bone marrow contained approximately SOYo lymphocytes.
Plasmapheresis was instituted shortly after admission, two units of plasma (600 cc) being reniovetl daily. After renioval of approximately 4,000 ml of plasma in seven days the patient's vision was improved, and there was clearing of retinal hemorrhages and decreased tortuosity of retinal veins. At this time total serum protein was reduced to 8.6 gni per 100 nil with 44% albumin and 37.30/, y globulins ( Table 2 ) . TgM was 4,400 mg per 100 ml, Is(; was 485 mg per 100 ml, and IgA was less than 10 nig per 100 ml. Cyclophosphamide, 100 mg daily, was iiistituted five days after admission. Two weeks later she was discharged and the cyclophosphamitle tlosc was increased to 150 mg per day.
T h e p i t icwt was re-admitted one month later at which linic 12 units (approximately 4,000 ml) of p l a m a were removed by plasmapheresis in a seven d:iy period. She subscqucntly did well on (y(:Iopliospliainide, 100-150 nig per t h y , for three months when she developctl a spoiitnneous right pncumothorax for which she required a brief hospitaliration. At subscquent monthly clinic visits neither hepatosplenomcgaly nor abnormal bleeding have been noted. Retinal scars persist, but no nrw retinal lesions have been noted.
Discussion
Plasniiilheresis was described its early a s 1914, when Abel et nl. 1 showed that experimental animals could tolerate chronic removal OT plasma if the removed red cells were returned to the animal. Plasmapheresis of human donors is now used by many blood banks to obtain relatively large amounts of plasma, plasma protein components, and platelets. Use ol plastic collection units with transfer packs obviates the need to enter the donated unit when separating plasma from cells, and thereby virtually eliminates the risk of contamination of the blood. Chronic plasmapheresis of 1,000 ml of plasma per week should not result in protein depletion in normal human donors.14 In contrast, removal of greater volumes of plasma per week results in reduction of serum proteins.* T h e latter is the rationale for this form of treatment in patients with Waldenstriim's macroglobulinemia.
Simple and effective, plasmapheresis for the purpose of decreasing pathologically elevated serum globulins and associated hyperviscosity has been the subject of several reports.5~ 7 9 10, 12, 15-17 Adams et u Z . ,~ in 1952, reported use of therapeutic plasmapheresis in a patient with multiple myeloma. Kemoval of I(i liters of plasma in 35 days resulted in transient depression of the plasma paraprotein level. Hyperviscosity syndrome can occur in patients with multiple myeloma as well as in patients with cryoglobulinemia and other non-Waldenstrom macroglobulinemias.l8 In two patients with hyperviscosity syndrome associated with multiple myeloma, treated by Smith and associates, vigorous plasniaplieresis achieved rapid lowering of serum viscosity, cessation of mucous membrane bleeding, and improvement in vision.17 Schwab and Fahey, 1960 ,Iz reported decreased serum viscosity antl macroglobulin levels, and both objective and subjective improvement in o~~lithalnio~~atliy, in two patients with Waldenstriini's macroglobulineniia treated with prolonged plasmapheresis. Skoog ct nZ.*5 demonstrated that removal of one unit of plasmii daily for 15 days from a patient with Waldenstriim's macroglobulinemia effected a significant drop in serum macroglobulin levels while concentration of other serum proteins remained relatively constant. Ten days after cessation of this treatment, IgM levels had returned nearly to those noted before treatment.
Bleeding tendencies in two patients with Waldenstriim's macroglobulinemia and one with multiple myeloma were treated by Godal and Horchgrevink7 by removing as little as 1,000-1,500 ml of plasma. This resulted in cessation of hemorrhage and shortening of bleeding times. A most significant study on this subject is that of Solomon and Fahey, l6 who reported clinical improvement in eight of ten patients witli macroglobulinemia treated with plasmapheresis at the National Institutes of Health (two of these patients had been reported previously) . I 2 Decreased cold intolerance, improvement in retinopathy, elevation of hematocrit, a,nd cessation of bleeding were noted. In nearly all patients, plasmapheresis therapy produced a fall in serum viscosity as well as in macroglobulin levels.
Objective decrease in retinopathy following plasmaplieresis has also been described by Skoog and associates.15 Fundic changes, i.e., vascular tortuosity and dilatation with or without thrombosis and hemorrhage are thought to be due to blood hyperviscosity and associated stagnation.18 Two of our patients manifested objective and subjective ocular improvement following plasmapheresis.
With the availability of serologic metliods for semiquantitation of serum IgM, the laboratory diagnosis of Waldenstriim's niacroglobulinemia no longer requires ultracentrifugal analysis of the seriim.3 Thus, even the small or medium-sized hospital laboratory can characterize the pathologic globulin immunochemically without determining tlie molecular weight.
Therapeutic plasmapheresis is not completely innocuous, and should not be used indiscriminately. Of concern is the possible depletion of platelets antl of normal immunoglobulins in patients undergoing intensive plasmapheresis. Kliman et al.8 showed that intensive plasmapheresis (five liters in five days) in normal donors resulted in a substantial decrease in serum albumin and globulin concentration. Moreover, the y globulins were tlie last fractions to return to normal. Because patients with gammopathy due to multiple myeloma or Waldenstrom's macroglobulinemia have increased numbers of infections antl an impaired antibody response,6 it is of interest that one of Godal and Borchgrevink's patients developed pneumonia following this treatment.7 However, Solomon and Faliey,*6 did not report infection as a complication in their ten patients, nor was this noted in our patients.
Platelet depletion by plasmapheresis can be minimized by re-infusing the buffy coat into the patient, together with tlie erythrocytes. This may be accomplished by utilizing a "hard" spin during centrifugation. Kliman et aZ.8 demonstrated an approximate 30 to 60 per cent drop in platelet count in
